Skip to main content

Table 5 Spearman correlation coefficient r with corresponding p-value in Non-ACLF and ACLF patients

From: Rotational thrombelastometry (ROTEM) improves hemostasis assessment compared to conventional coagulation test in ACLF and Non-ACLF patients

 

Non-ACLF

n = 55

r / p

ACLF

n = 22

r / p

A

NATEM

CT

CFT

MCF

CT

CFT

MCF

PT (Quick)

0.29 / 0.04

− 0.04 / 0.76

0.25 / 0.07

− 0.05 / 0.71

0.32 / 0.83

− 0.05 / 0.16

INR

−0.28 / 0.04

0.06 / 0.68

−0.26 / 0.05

− 0.06 / 0.81

0.08 / 0.75

− 0.32 / 0.16

aPTT

−0.07 / 0.64

0.28 / 0.04

− 0.34 / 0.01

0.14 / 0.55

0.27 / 0.24

− 0.40 / 0.08

Platelets

−0.01 / 0.93

−0.55 / < 0.0001

0.71 / < 0.0001

−0.36 / 0.11

− 0.47 / 0.03

0.62 / 0.003

Fibrinogen

0.01 / 0.92

−0.36 / 0.008

0.53 / < 0.0001

− 0.02 / 0.92

− 0.41 / 0.06

0.68 / 0.001

Antithrombin III-activity

0.31 / 0.02

−0.20 / 0.15

0.45 / 0.001

−0.04 / 0.87

− 0.31 / 0.17

0.65 / 0.001

Factor V

0.14 / 0.33

−0.30 / 0.03

0.45 / 0.001

0.17 / 0.45

−0.11 / 0.64

0.43 / 0.05

Factor VIII

−0.25 / 0.07

−0.42 / 0.002

0.29 / 0.04

−0.37 / 0.10

− 0.52 / 0.02

0.50 / 0.02

B

INTEM

CT

CFT

MCF

CT

CFT

MCF

PT (Quick)

−0.08 / 0.56

− 0.31 / 0.02

0.44 / 0.001

−0.54 / 0.012

− 0.13 / 0.58

0.21 / 0.36

INR

0.09 / 0.52

0.33 / 0.01

−0.46 / < 0.0001

0.56 / 0.009

0.12 / 0.60

−0.22 / 0.34

aPTT

0.44 / 0.001

0.32 / 0.02

−0.42 / 0.002

0.637 / 0.002

0.21 / 0.37

−0.26 / 0.26

Platelet count

−0.22 / 0.11

− 0.79 / < 0.0001

0.78 / < 0.0001

− 0.05 / 0.82

−0.80 / < 0.0001

0.73 / < 0.0001

Fibrinogen

−0.32 / 0.02

− 0.61 / < 0.0001

0.68 / < 0.0001

−0.44 / 0.047

− 0.45 / 0.04

0.60 / 0.004

Antithrombin III-activity

−0.27 / 0.045

− 0.515 / < 0.0001

0.63 / < 0.0001

− 0.52 / 0.02

− 0.44 / 0.047

0.53 / 0.01

Factor V

− 0.26 / 0.05

− 0.48 / < 0.0001

0.56 / < 0.0001

− 0.37 / 0.10

− 0.34 / 0.14

0.36 / 0.11

Factor VIII

− 0.26 / 0.06

− 0.34 / 0.01

0.27 / 0.04

− 0.07 / 0.76

− 0.50 / 0.02

0.43 / 0.05

C

EXTEM

CT

CFT

MCF

CT

CFT

MCF

PT (Quick)

−0.01 / 0.94

− 0.29 / 0.03

0.44 / 0.001

−0.4 / 0.02

− 0.20 / 0.38

0.29 / 0.19

INR

0.003 / 0.98

0.31 / 0.02

−0.46 / < 0.0001

0.49 / 0.02

0.23 / 0.31

−0.32 / 0.15

aPTT

0.03 / 0.83

0.23 / 0.10

−0.40 / 0.003

0.53 / 0.01

0.27 / 0.23

−0.35 / 0.11

Platelet count

0.10 / 0.47

−0.75 / < 0.0001

0.76 / < 0.0001

− 0.58 / 0.005

− 0.74 / < 0.0001

0.73 / < 0.0001

Fibrinogen

0.08 / 0.54

− 0.613 / < 0.0001

0.70 / < 0.0001

− 0.46 / 0.03

− 0.59 / 0.004

0.67 / 0.001

Antithrombin III-activity

0.28 / 0.04

− 0.50 / < 0.0001

0.64 / < 0.0001

−0.67 / 0.001

− 0.46 / 0.03

0.57 / 0.006

Factor V

0.07 / 0.64

−0.42 / 0.001

0.56 / < 0.0001

−0.47 / 0.03

− 0.32 / 0.15

0.40 / 0.06

Factor VIII

−0.10 / 0.48

−0.31 / 0.02

0.25 / 0.07

−0.21 / 0.35

− 0.46 / 0.03

0.42 / 0.05

D

FIBTEM

MCF

MCF

PT (Quick)

0.36 / 0.007

0.48 / 0.02

INR

−0.38 / 0.005

−0.48 / 0.02

aPTT

−0.36 / 0.008

−0.52 / 0.01

Platelet count

0.47 / < 0.0001

0.52 / 0.013

Fibrinogen

0.73 / < 0.0001

0.66 / 0.001

Antithrombin III-activity

0.58 / < 0.0001

0.65 / 0.001

Factor V

0.53 / < 0.0001

0.69 / < 0.0001

Factor VIII

0.36 / 0.007

0.34 / 0.12

  1. ACLF acute-on-chronic liver failure, INR international normalized ratio, aPTT activated partial thromboplastin time